Back to results
US 2009/0155303 A1Published application
Cpg single strand deoxynucleotides for use as adjuvant
AssigneeChangchun Huapu Biotechnology Co., Ltd.
InventorsLiying Wang, Musheng Bao, Yongli Yu
Life of this patent
Estimating the term…
Abstract
The present invention provides an adjuvant, which includes at least one single strand deoxynucleotide containing a CpG dinucleotide. The single strand deoxynucleotide comprises one or more CpG dinucleotides. When used in combination with rabies vaccine, HBV vaccine or other vaccines, the adjuvant can significantly improve the immune effect of the vaccine.
Claims11
A method of improving immunogenicity of a vaccine, comprising coadministering said vaccine to a subject with at least one single strand deoxynucleotide, comprising one or more CpG dinucleotides and a vaccine.
Dependencies are inferred from the claim text.